Premium
Fulminant type 1 diabetes mellitus triggered by coronavirus disease 2019 vaccination in an advanced melanoma patient given adjuvant nivolumab therapy
Author(s) -
Ohuchi Kentaro,
Amagai Ryo,
Tamabuchi Erika,
Kambayashi Yumi,
Fujimura Taku
Publication year - 2022
Publication title -
the journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.9
H-Index - 65
eISSN - 1346-8138
pISSN - 0385-2407
DOI - 10.1111/1346-8138.16304
Subject(s) - nivolumab , medicine , fulminant , adjuvant , vaccination , melanoma , disease , adjuvant therapy , virology , immunology , immunotherapy , cancer , cancer research
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom